Home Other Building Blocks 9-Ethyl-9h-purin-6-amine

9-Ethyl-9h-purin-6-amine

CAS No.:
2715-68-6
Catalog Number:
AG0034F7
Molecular Formula:
C7H9N5
Molecular Weight:
163.1799
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
250mg
95%
In Stock USA
United States
$132
- +
1g
95%
In Stock USA
United States
$313
- +
Product Description
Catalog Number:
AG0034F7
Chemical Name:
9-Ethyl-9h-purin-6-amine
CAS Number:
2715-68-6
Molecular Formula:
C7H9N5
Molecular Weight:
163.1799
MDL Number:
MFCD00037989
IUPAC Name:
9-ethylpurin-6-amine
InChI:
InChI=1S/C7H9N5/c1-2-12-4-11-5-6(8)9-3-10-7(5)12/h3-4H,2H2,1H3,(H2,8,9,10)
InChI Key:
MUIPLRMGAXZWSQ-UHFFFAOYSA-N
SMILES:
CCn1cnc2c1ncnc2N
NSC Number:
14580
Properties
Complexity:
162  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
163.086g/mol
Formal Charge:
0
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
163.184g/mol
Monoisotopic Mass:
163.086g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
69.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.2  
Literature
Title Journal
Bipyrimidine ruthenium(II) arene complexes: structure, reactivity and cytotoxicity. Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20121001
Organometallic half-sandwich iridium anticancer complexes. Journal of medicinal chemistry 20110428
Pharmacological and physiological characterization of the tremulous jaw movement model of parkinsonian tremor: potential insights into the pathophysiology of tremor. Frontiers in systems neuroscience 20110101
Molecularly imprinted polymers: present and future prospective. International journal of molecular sciences 20110101
A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug. Neuropharmacology 20100301
Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes. Journal of medicinal chemistry 20091210
Adenosine A2A receptor antagonists: new 8-substituted 9-ethyladenines as tools for in vivo rat models of Parkinson's disease. ChemMedChem 20090601
8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands. Bioorganic & medicinal chemistry 20090401
Organometallic osmium(II) arene anticancer complexes containing picolinate derivatives. Inorganic chemistry 20090216
Structural assignment of adenine aggregates in CDCl3. The Journal of chemical physics 20080521
Phthalocyanine-based molecularly imprinted polymers as nucleoside receptors. Metal-based drugs 20080101
An enolisable barbiturate with adjustable hydrogen-bonding structure for UV/Vis detection of nucleic acid bases and related compounds. Chemistry (Weinheim an der Bergstrasse, Germany) 20080101
Unprecedented head-to-head right-handed cross-links between the antitumor bis(mu-N,N'-di-p-tolylformamidinate) dirhodium(II,II) core and the dinucleotide d(ApA) with the adenine bases in the rare imino form. Journal of the American Chemical Society 20071017
A hydrogen-bonded channel structure formed by a complex of uracil and melamine. Beilstein journal of organic chemistry 20070101
Synthesis and biological activity of trisubstituted adenines as A 2A adenosine receptor antagonists. Nucleosides, nucleotides & nucleic acids 20070101
Facile synthesis and detailed characterization of a new ferrocenyl uracil peptide nucleic acid monomer. The Journal of organic chemistry 20060929
Reaction of acrolein with 2'-deoxyadenosine and 9-ethyladenine--formation of cyclic adducts. Bioorganic chemistry 20060201
Stabilization of the non-canonical adenine-adeninium base pair by N(7) coordination of Zn(II). Journal of inorganic biochemistry 20051101
2- and 8-alkynyl-9-ethyladenines: Synthesis and biological activity at human and rat adenosine receptors. Purinergic signalling 20050601
New adenosine A2A receptor antagonists: actions on Parkinson's disease models. European journal of pharmacology 20050411
Gas-phase acidity studies of multiple sites of adenine and adenine derivatives. The Journal of organic chemistry 20041015
Feasibility of a two-metal, four-purine nucleobase quartet motif. Inorganic chemistry 20040906
Preparation and evaluation of molecularly imprinted polymers based on 9-ethyladenine for the recognition of nucleotide bases in capillary electrochromatography. Electrophoresis 20040201
Neuroprotective effect of adenine on purkinje cell survival in rat cerebellar primary cultures. Journal of neuroscience research 20031201
9-Ethyladenine derivatives as adenosine receptor antagonists: 2- and 8-substitution results in distinct selectivities. Naunyn-Schmiedeberg's archives of pharmacology 20030601
Minor groove site coordination of adenine by platinum group metal ions: effects on basicity, base pairing, and electronic structure. Inorganic chemistry 20030505
Fluorescent 7- and 8-methyl etheno derivatives of adenosine and 6-amino-9-ethylpurine: syntheses and fluorescence properties. Nucleosides, nucleotides & nucleic acids 20030101
Acidity of adenine and adenine derivatives and biological implications. A computational and experimental gas-phase study. The Journal of organic chemistry 20021129
Association patterns of platinated purine nucleobases in metal-modified pairs and triples. Inorganic chemistry 20021118
Rebek imides and their adenine complexes: preferences for Hoogsteen binding in the solid state and in solution. Chemistry (Weinheim an der Bergstrasse, Germany) 20020104
Cyanurate mimics of hydrogen-bonding patterns of nucleic bases: crystal structure of a 1:1 molecular complex of 9-ethyladenine and N-methylcyanuric acid. Organic letters 20010111
Structure-activity relationships for the binding of ligands to xanthine or guanine phosphoribosyl-transferase from Toxoplasma gondii. Biochemical pharmacology 19951109
Properties